Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2017	Mar. 27, 2016	Mar. 26, 2017	Mar. 27, 2016
Document Period End Date			Mar. 26, 2017
Revenue, net	$ 341,505	$ 366,919	$ 1,114,064	$ 1,228,214
Cost of revenue, net	255,429	257,886	777,490	854,163
Gross profit	86,076	109,033	336,574	374,051
Operating expenses:
Research and development	41,451	41,871	119,292	127,363
Sales, general and administrative	68,165	64,489	213,136	214,443
Amortization or impairment of acquisition-related intangibles	8,362	7,318	20,707	21,442
Loss (gain) on disposal or impairment of long-lived assets	500	(104)	1,541	16,483
Gain (Loss) on Contract Termination	(12,500)	0	(12,500)	0
Total operating expenses	105,978	113,574	342,176	379,731
Operating loss	(19,902)	(4,541)	(5,602)	(5,680)
Non-operating income (expense), net	9,865	717	4,946	(14,075)
Loss before income taxes	(10,037)	(3,824)	(656)	(19,755)
Income tax expense (benefit)	88,976	(3,976)	91,574	(8,860)
Net income (loss)	$ (99,013)	$ 152	$ (92,230)	$ (10,895)
(Loss) earnings per share:
Basic	$ (1.02)	$ 0.00	$ (0.93)	$ (0.11)
Diluted	$ (1.02)	$ 0.00	$ (0.93)	$ (0.11)
Weighted average shares used in per share calculation:
Basic	97,346	100,606	98,791	102,157
Diluted	97,346	101,221	98,791	102,157